Review



fsl 1  (InvivoGen)


Bioz Verified Symbol InvivoGen is a verified supplier
Bioz Manufacturer Symbol InvivoGen manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    InvivoGen fsl 1
    Functional reconstitution of TLR2 heterodimers enables NF‐κB activation by synthetic TLR2 agonists in gastric epithelial cells. (A, D) GES‐1–NF‐κB RE (A) and AGS–NF‐κB RE (D) reporter cells transfected with the empty control plasmid (pDuo‐MCS) were stimulated with synthetic TLR2 agonists (Pam2CSK4, PAM2, 10 µg/mL; Pam3CSK4, PAM3, 10 µg/mL; CU‐T12‐9, 10 µM; or <t>FSL‐1,</t> 10 µg/mL) or with Escherichia coli LPS (1 µg/mL) and analyzed for NF‐κB–dependent reporter activity. Tumour necrosis factor (TNF; 20 ng/mL) was included as a positive control. (B, E) GES‐1–NF‐κB RE (B) and AGS–NF‐κB RE (E) reporter cells constitutively expressing the TLR2/6 heterodimer were stimulated with the indicated TLR2 agonists, E. coli LPS, or TNF. (C, F) GES‐1–NF‐κB RE (C) and AGS–NF‐κB RE (F) reporter cells constitutively expressing the TLR2/1 heterodimer were stimulated with the indicated agonists under the same conditions. NF‐κB activation was quantified by luciferase assay and expressed as relative light units (RLU) relative to unstimulated control cells. Bars represent the mean ± SD ( n = 3).
    Fsl 1, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 705 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fsl+1/FSL-1/pmc13619146-66-26-27
    Average 99 stars, based on 705 article reviews
    fsl 1 - by Bioz Stars, 2026-11
    99/100 stars

    Images

    1) Product Images from "Helicobacter pylori Outer Membrane Vesicles Engage TLR2 Through NapA to Promote Epithelial Association and Inflammatory Signalling"

    Article Title: Helicobacter pylori Outer Membrane Vesicles Engage TLR2 Through NapA to Promote Epithelial Association and Inflammatory Signalling

    Journal: Journal of Extracellular Vesicles

    doi: 10.1002/jev2.70376

    Functional reconstitution of TLR2 heterodimers enables NF‐κB activation by synthetic TLR2 agonists in gastric epithelial cells. (A, D) GES‐1–NF‐κB RE (A) and AGS–NF‐κB RE (D) reporter cells transfected with the empty control plasmid (pDuo‐MCS) were stimulated with synthetic TLR2 agonists (Pam2CSK4, PAM2, 10 µg/mL; Pam3CSK4, PAM3, 10 µg/mL; CU‐T12‐9, 10 µM; or FSL‐1, 10 µg/mL) or with Escherichia coli LPS (1 µg/mL) and analyzed for NF‐κB–dependent reporter activity. Tumour necrosis factor (TNF; 20 ng/mL) was included as a positive control. (B, E) GES‐1–NF‐κB RE (B) and AGS–NF‐κB RE (E) reporter cells constitutively expressing the TLR2/6 heterodimer were stimulated with the indicated TLR2 agonists, E. coli LPS, or TNF. (C, F) GES‐1–NF‐κB RE (C) and AGS–NF‐κB RE (F) reporter cells constitutively expressing the TLR2/1 heterodimer were stimulated with the indicated agonists under the same conditions. NF‐κB activation was quantified by luciferase assay and expressed as relative light units (RLU) relative to unstimulated control cells. Bars represent the mean ± SD ( n = 3).
    Figure Legend Snippet: Functional reconstitution of TLR2 heterodimers enables NF‐κB activation by synthetic TLR2 agonists in gastric epithelial cells. (A, D) GES‐1–NF‐κB RE (A) and AGS–NF‐κB RE (D) reporter cells transfected with the empty control plasmid (pDuo‐MCS) were stimulated with synthetic TLR2 agonists (Pam2CSK4, PAM2, 10 µg/mL; Pam3CSK4, PAM3, 10 µg/mL; CU‐T12‐9, 10 µM; or FSL‐1, 10 µg/mL) or with Escherichia coli LPS (1 µg/mL) and analyzed for NF‐κB–dependent reporter activity. Tumour necrosis factor (TNF; 20 ng/mL) was included as a positive control. (B, E) GES‐1–NF‐κB RE (B) and AGS–NF‐κB RE (E) reporter cells constitutively expressing the TLR2/6 heterodimer were stimulated with the indicated TLR2 agonists, E. coli LPS, or TNF. (C, F) GES‐1–NF‐κB RE (C) and AGS–NF‐κB RE (F) reporter cells constitutively expressing the TLR2/1 heterodimer were stimulated with the indicated agonists under the same conditions. NF‐κB activation was quantified by luciferase assay and expressed as relative light units (RLU) relative to unstimulated control cells. Bars represent the mean ± SD ( n = 3).

    Techniques Used: Functional Assay, Activation Assay, Transfection, Control, Plasmid Preparation, Activity Assay, Positive Control, Expressing, Luciferase

    Functional validation of TLR2/1‐ and TLR2/6‐specific NF‐κB reporter cells using heterodimer‐selective agonists and purified LPS. (A, B, D, E) GES‐1 (A, B) and AGS (D, E) NF‐κB reporter cells stably expressing either the TLR2/6 or TLR2/1 heterodimer were stimulated for 5 h with the TLR2/6‐selective agonists FSL‐1 or Pam2CSK4 (Pam2), or with the TLR2/1‐selective agonists CU‐T12‐9 or Pam3CSK4 (Pam3), over the indicated concentration ranges (1–1,000 ng/mL for peptide agonists and 1–1,000 nM for CU‐T12‐9). (C, F) GES‐1 (C) and AGS (F) reporter cells expressing either TLR2/1 or TLR2/6 were stimulated for 5 h with increasing concentrations of purified E. coli LPS (1–1,000 ng/mL; 0.14–140 nM Kdo equivalents). (G) Representative colorimetric Kdo assay used for LPS quantification. (H) Standard curve generated with commercially available 2‐keto‐3‐deoxyoctonate (Kdo) and used for normalization of purified LPS preparations. (I) AGS NF‐κB reporter cells expressing either the TLR2/1 or TLR2/6 heterodimer were stimulated for 5 h with purified H. pylori strain 26695 LPS normalized according to Kdo content (0.14–1,400 nM Kdo equivalents). NF‐κB‐dependent luminescent reporter activity was measured after stimulation and expressed as relative light units (RLUs) normalized to untreated controls. Bars represent the mean ± SD of three independent experiments. Statistical significance is indicated as * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
    Figure Legend Snippet: Functional validation of TLR2/1‐ and TLR2/6‐specific NF‐κB reporter cells using heterodimer‐selective agonists and purified LPS. (A, B, D, E) GES‐1 (A, B) and AGS (D, E) NF‐κB reporter cells stably expressing either the TLR2/6 or TLR2/1 heterodimer were stimulated for 5 h with the TLR2/6‐selective agonists FSL‐1 or Pam2CSK4 (Pam2), or with the TLR2/1‐selective agonists CU‐T12‐9 or Pam3CSK4 (Pam3), over the indicated concentration ranges (1–1,000 ng/mL for peptide agonists and 1–1,000 nM for CU‐T12‐9). (C, F) GES‐1 (C) and AGS (F) reporter cells expressing either TLR2/1 or TLR2/6 were stimulated for 5 h with increasing concentrations of purified E. coli LPS (1–1,000 ng/mL; 0.14–140 nM Kdo equivalents). (G) Representative colorimetric Kdo assay used for LPS quantification. (H) Standard curve generated with commercially available 2‐keto‐3‐deoxyoctonate (Kdo) and used for normalization of purified LPS preparations. (I) AGS NF‐κB reporter cells expressing either the TLR2/1 or TLR2/6 heterodimer were stimulated for 5 h with purified H. pylori strain 26695 LPS normalized according to Kdo content (0.14–1,400 nM Kdo equivalents). NF‐κB‐dependent luminescent reporter activity was measured after stimulation and expressed as relative light units (RLUs) normalized to untreated controls. Bars represent the mean ± SD of three independent experiments. Statistical significance is indicated as * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

    Techniques Used: Functional Assay, Biomarker Discovery, Purification, Stable Transfection, Expressing, Concentration Assay, Standard Curve, Generated, Activity Assay

    Related Articles

    Mouse Assay:

    Article Title: Overweight and obesity induce Toll-like receptor 2-induced Type I IFN signaling
    Article Snippet: Visualization of Pathway analysis of differentially expressed genes within cell types was performed by using Ingenuity Pathway Analysis (Qiagen Bioinformatics, Redwood City, California). .. Mice were fed either the standard diet or WD for 7 days and then injected intraperitoneally with FSL-1 (1 mg/kg body weight; cat#: tlrl-fsl, InvivoGen). .. Visualization of Pathway analysis of differentially expressed genes within cell types was performed by using Ingenuity Pathway Analysis (Qiagen Bioinformatics, Redwood City, California).

    Injection:

    Article Title: Overweight and obesity induce Toll-like receptor 2-induced Type I IFN signaling
    Article Snippet: Visualization of Pathway analysis of differentially expressed genes within cell types was performed by using Ingenuity Pathway Analysis (Qiagen Bioinformatics, Redwood City, California). .. Mice were fed either the standard diet or WD for 7 days and then injected intraperitoneally with FSL-1 (1 mg/kg body weight; cat#: tlrl-fsl, InvivoGen). .. Visualization of Pathway analysis of differentially expressed genes within cell types was performed by using Ingenuity Pathway Analysis (Qiagen Bioinformatics, Redwood City, California).

    other:

    Article Title: EM982, an erythromycin derivative, modulates TLR2 ligand-induced cytokine production
    Article Snippet: The culture supernatant was added to QUANTI-Blue Solution (InvivoGen) and incubated for 2 h at 37 ◦C.

    Article Title: Toll-like receptor 2 coordinates induction of IL-22 in lung macrophages following organic dust-induced inflammation
    Article Snippet: TLR2/6 , FSL-1 , InvivoGen; 100 ng/mL , #Tlrl-fsl.

    Clone Assay:

    Article Title: Helicobacter pylori Outer Membrane Vesicles Engage TLR2 Through NapA to Promote Epithelial Association and Inflammatory Signalling
    Article Snippet: .. To validate the responsiveness of the reporter clones, TLR2/1–NF‐κB cells were stimulated with Pam3CSK4 (InvivoGen) and CU‐T12‐9 (Tocris), and TLR2/6–NF‐κB cells were stimulated with Pam2CSK4 and FSL‐1 (InvivoGen). ..

    Purification:

    Article Title: Staphylococcus aureus derived extracellular vesicles modulate osteoblast-like cell immune responses independently of vesicle internalization.
    Article Snippet: .. After 48 h, cells were stimulated with purified EVs at different doses (from 5 x 105 to 5 x 107 particles/mL for HEK-Blue hTLR2 and from 7.5 x 108 to 5.0 x 1010 particles/mL for HEK-Blue hTLR7) for 24 h. 10 ng/mL of FSL-1 (tlrl-fsl, INVIVOGEN) or 100 ng/mL of R848 (tlrl-r848-1, INVIVOGEN) treated cells were used as a positive control for HEK-Blue hTLR2 and HEK-Blue hTLR7 respectively. .. Cell culture supernatants were assayed for SEAP activity by incubating 20 μL of supernatant with 180 μL of QUANTI-Blue solution (INVIVOGEN) at 37°C, according to the manufacturer’s instructions.

    Article Title: Staphylococcus aureus derived extracellular vesicles modulate osteoblast-like cell immune responses independently of vesicle internalization
    Article Snippet: .. After 48 h, cells were stimulated with purified EVs at different doses (from 5 × 10 5 to 5 × 10 7 particles/mL for HEK-Blue hTLR2 and from 7.5 × 10 8 to 5.0 × 10 10 particles/mL for HEK-Blue hTLR7) for 24 h. 10 ng/mL of FSL-1 (tlrl-fsl, INVIVOGEN) or 100 ng/mL of R848 (tlrl-r848-1, INVIVOGEN) treated cells were used as a positive control for HEK-Blue hTLR2 and HEK-Blue hTLR7 respectively. .. Cell culture supernatants were assayed for SEAP activity by incubating 20 μL of supernatant with 180 μL of QUANTI-Blue solution (INVIVOGEN) at 37 °C, according to the manufacturer’s instructions.

    Positive Control:

    Article Title: Staphylococcus aureus derived extracellular vesicles modulate osteoblast-like cell immune responses independently of vesicle internalization.
    Article Snippet: .. After 48 h, cells were stimulated with purified EVs at different doses (from 5 x 105 to 5 x 107 particles/mL for HEK-Blue hTLR2 and from 7.5 x 108 to 5.0 x 1010 particles/mL for HEK-Blue hTLR7) for 24 h. 10 ng/mL of FSL-1 (tlrl-fsl, INVIVOGEN) or 100 ng/mL of R848 (tlrl-r848-1, INVIVOGEN) treated cells were used as a positive control for HEK-Blue hTLR2 and HEK-Blue hTLR7 respectively. .. Cell culture supernatants were assayed for SEAP activity by incubating 20 μL of supernatant with 180 μL of QUANTI-Blue solution (INVIVOGEN) at 37°C, according to the manufacturer’s instructions.

    Article Title: Staphylococcus aureus derived extracellular vesicles modulate osteoblast-like cell immune responses independently of vesicle internalization
    Article Snippet: .. After 48 h, cells were stimulated with purified EVs at different doses (from 5 × 10 5 to 5 × 10 7 particles/mL for HEK-Blue hTLR2 and from 7.5 × 10 8 to 5.0 × 10 10 particles/mL for HEK-Blue hTLR7) for 24 h. 10 ng/mL of FSL-1 (tlrl-fsl, INVIVOGEN) or 100 ng/mL of R848 (tlrl-r848-1, INVIVOGEN) treated cells were used as a positive control for HEK-Blue hTLR2 and HEK-Blue hTLR7 respectively. .. Cell culture supernatants were assayed for SEAP activity by incubating 20 μL of supernatant with 180 μL of QUANTI-Blue solution (INVIVOGEN) at 37 °C, according to the manufacturer’s instructions.



    Similar Products

    94
    MedChemExpress fsl 1
    Fsl 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fsl+1/FSL-1/pm42966103-101-67-69
    Average 94 stars, based on 1 article reviews
    fsl 1 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    99
    InvivoGen fsl 1
    Functional reconstitution of TLR2 heterodimers enables NF‐κB activation by synthetic TLR2 agonists in gastric epithelial cells. (A, D) GES‐1–NF‐κB RE (A) and AGS–NF‐κB RE (D) reporter cells transfected with the empty control plasmid (pDuo‐MCS) were stimulated with synthetic TLR2 agonists (Pam2CSK4, PAM2, 10 µg/mL; Pam3CSK4, PAM3, 10 µg/mL; CU‐T12‐9, 10 µM; or <t>FSL‐1,</t> 10 µg/mL) or with Escherichia coli LPS (1 µg/mL) and analyzed for NF‐κB–dependent reporter activity. Tumour necrosis factor (TNF; 20 ng/mL) was included as a positive control. (B, E) GES‐1–NF‐κB RE (B) and AGS–NF‐κB RE (E) reporter cells constitutively expressing the TLR2/6 heterodimer were stimulated with the indicated TLR2 agonists, E. coli LPS, or TNF. (C, F) GES‐1–NF‐κB RE (C) and AGS–NF‐κB RE (F) reporter cells constitutively expressing the TLR2/1 heterodimer were stimulated with the indicated agonists under the same conditions. NF‐κB activation was quantified by luciferase assay and expressed as relative light units (RLU) relative to unstimulated control cells. Bars represent the mean ± SD ( n = 3).
    Fsl 1, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fsl+1/FSL-1/pmc13619146-66-26-27
    Average 99 stars, based on 1 article reviews
    fsl 1 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    InvivoGen fla st

    Fla St, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fsl+1/FSL-1/pmc13532049-541-25-26
    Average 99 stars, based on 1 article reviews
    fla st - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    InvivoGen fsl 1 pam2cgdpkhpksf

    Fsl 1 Pam2cgdpkhpksf, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fsl+1/FSL-1/bio_rxiv__64898__2026__06__03__729882-361-6-8
    Average 99 stars, based on 1 article reviews
    fsl 1 pam2cgdpkhpksf - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    Image Search Results


    Functional reconstitution of TLR2 heterodimers enables NF‐κB activation by synthetic TLR2 agonists in gastric epithelial cells. (A, D) GES‐1–NF‐κB RE (A) and AGS–NF‐κB RE (D) reporter cells transfected with the empty control plasmid (pDuo‐MCS) were stimulated with synthetic TLR2 agonists (Pam2CSK4, PAM2, 10 µg/mL; Pam3CSK4, PAM3, 10 µg/mL; CU‐T12‐9, 10 µM; or FSL‐1, 10 µg/mL) or with Escherichia coli LPS (1 µg/mL) and analyzed for NF‐κB–dependent reporter activity. Tumour necrosis factor (TNF; 20 ng/mL) was included as a positive control. (B, E) GES‐1–NF‐κB RE (B) and AGS–NF‐κB RE (E) reporter cells constitutively expressing the TLR2/6 heterodimer were stimulated with the indicated TLR2 agonists, E. coli LPS, or TNF. (C, F) GES‐1–NF‐κB RE (C) and AGS–NF‐κB RE (F) reporter cells constitutively expressing the TLR2/1 heterodimer were stimulated with the indicated agonists under the same conditions. NF‐κB activation was quantified by luciferase assay and expressed as relative light units (RLU) relative to unstimulated control cells. Bars represent the mean ± SD ( n = 3).

    Journal: Journal of Extracellular Vesicles

    Article Title: Helicobacter pylori Outer Membrane Vesicles Engage TLR2 Through NapA to Promote Epithelial Association and Inflammatory Signalling

    doi: 10.1002/jev2.70376

    Figure Lengend Snippet: Functional reconstitution of TLR2 heterodimers enables NF‐κB activation by synthetic TLR2 agonists in gastric epithelial cells. (A, D) GES‐1–NF‐κB RE (A) and AGS–NF‐κB RE (D) reporter cells transfected with the empty control plasmid (pDuo‐MCS) were stimulated with synthetic TLR2 agonists (Pam2CSK4, PAM2, 10 µg/mL; Pam3CSK4, PAM3, 10 µg/mL; CU‐T12‐9, 10 µM; or FSL‐1, 10 µg/mL) or with Escherichia coli LPS (1 µg/mL) and analyzed for NF‐κB–dependent reporter activity. Tumour necrosis factor (TNF; 20 ng/mL) was included as a positive control. (B, E) GES‐1–NF‐κB RE (B) and AGS–NF‐κB RE (E) reporter cells constitutively expressing the TLR2/6 heterodimer were stimulated with the indicated TLR2 agonists, E. coli LPS, or TNF. (C, F) GES‐1–NF‐κB RE (C) and AGS–NF‐κB RE (F) reporter cells constitutively expressing the TLR2/1 heterodimer were stimulated with the indicated agonists under the same conditions. NF‐κB activation was quantified by luciferase assay and expressed as relative light units (RLU) relative to unstimulated control cells. Bars represent the mean ± SD ( n = 3).

    Article Snippet: To validate the responsiveness of the reporter clones, TLR2/1–NF‐κB cells were stimulated with Pam3CSK4 (InvivoGen) and CU‐T12‐9 (Tocris), and TLR2/6–NF‐κB cells were stimulated with Pam2CSK4 and FSL‐1 (InvivoGen).

    Techniques: Functional Assay, Activation Assay, Transfection, Control, Plasmid Preparation, Activity Assay, Positive Control, Expressing, Luciferase

    Functional validation of TLR2/1‐ and TLR2/6‐specific NF‐κB reporter cells using heterodimer‐selective agonists and purified LPS. (A, B, D, E) GES‐1 (A, B) and AGS (D, E) NF‐κB reporter cells stably expressing either the TLR2/6 or TLR2/1 heterodimer were stimulated for 5 h with the TLR2/6‐selective agonists FSL‐1 or Pam2CSK4 (Pam2), or with the TLR2/1‐selective agonists CU‐T12‐9 or Pam3CSK4 (Pam3), over the indicated concentration ranges (1–1,000 ng/mL for peptide agonists and 1–1,000 nM for CU‐T12‐9). (C, F) GES‐1 (C) and AGS (F) reporter cells expressing either TLR2/1 or TLR2/6 were stimulated for 5 h with increasing concentrations of purified E. coli LPS (1–1,000 ng/mL; 0.14–140 nM Kdo equivalents). (G) Representative colorimetric Kdo assay used for LPS quantification. (H) Standard curve generated with commercially available 2‐keto‐3‐deoxyoctonate (Kdo) and used for normalization of purified LPS preparations. (I) AGS NF‐κB reporter cells expressing either the TLR2/1 or TLR2/6 heterodimer were stimulated for 5 h with purified H. pylori strain 26695 LPS normalized according to Kdo content (0.14–1,400 nM Kdo equivalents). NF‐κB‐dependent luminescent reporter activity was measured after stimulation and expressed as relative light units (RLUs) normalized to untreated controls. Bars represent the mean ± SD of three independent experiments. Statistical significance is indicated as * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

    Journal: Journal of Extracellular Vesicles

    Article Title: Helicobacter pylori Outer Membrane Vesicles Engage TLR2 Through NapA to Promote Epithelial Association and Inflammatory Signalling

    doi: 10.1002/jev2.70376

    Figure Lengend Snippet: Functional validation of TLR2/1‐ and TLR2/6‐specific NF‐κB reporter cells using heterodimer‐selective agonists and purified LPS. (A, B, D, E) GES‐1 (A, B) and AGS (D, E) NF‐κB reporter cells stably expressing either the TLR2/6 or TLR2/1 heterodimer were stimulated for 5 h with the TLR2/6‐selective agonists FSL‐1 or Pam2CSK4 (Pam2), or with the TLR2/1‐selective agonists CU‐T12‐9 or Pam3CSK4 (Pam3), over the indicated concentration ranges (1–1,000 ng/mL for peptide agonists and 1–1,000 nM for CU‐T12‐9). (C, F) GES‐1 (C) and AGS (F) reporter cells expressing either TLR2/1 or TLR2/6 were stimulated for 5 h with increasing concentrations of purified E. coli LPS (1–1,000 ng/mL; 0.14–140 nM Kdo equivalents). (G) Representative colorimetric Kdo assay used for LPS quantification. (H) Standard curve generated with commercially available 2‐keto‐3‐deoxyoctonate (Kdo) and used for normalization of purified LPS preparations. (I) AGS NF‐κB reporter cells expressing either the TLR2/1 or TLR2/6 heterodimer were stimulated for 5 h with purified H. pylori strain 26695 LPS normalized according to Kdo content (0.14–1,400 nM Kdo equivalents). NF‐κB‐dependent luminescent reporter activity was measured after stimulation and expressed as relative light units (RLUs) normalized to untreated controls. Bars represent the mean ± SD of three independent experiments. Statistical significance is indicated as * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

    Article Snippet: To validate the responsiveness of the reporter clones, TLR2/1–NF‐κB cells were stimulated with Pam3CSK4 (InvivoGen) and CU‐T12‐9 (Tocris), and TLR2/6–NF‐κB cells were stimulated with Pam2CSK4 and FSL‐1 (InvivoGen).

    Techniques: Functional Assay, Biomarker Discovery, Purification, Stable Transfection, Expressing, Concentration Assay, Standard Curve, Generated, Activity Assay

    Journal: Immunity

    Article Title: Brain endothelial cells orchestrate a neuroprotective antiviral state in the central nervous system in response to peripheral viral pattern sensing

    doi: 10.1016/j.immuni.2026.06.009

    Figure Lengend Snippet:

    Article Snippet: PAMPs used were PAM3CSK4 (Invivogen, Cat# tlrl-pms, 10μg per dose), HMW poly(I:C) (Invivogen, Cat# tlrl-pic, 50μg per dose), LPS-EK (Invivogen, Cat# tlrl-eklps, 10μg per dose), FLA-ST (Invivogen, Cat# tlrl-stfla, 10μg per dose), FSL1 (Invivogen, Cat# tlrl-fsl, 5μg per dose), R848 Resiquimod (Invivogen, Cat# tlrl-r848–1, 10μg per dose), and ODN1826 (Invivogen, Cat# tlrl1826, 3.2 μg per dose).

    Techniques: Cell-Signaling, Virus, Recombinant, Staining, Red Blood Cell Lysis, Protease Inhibitor, SYBR Green Assay, cDNA Synthesis, Reverse Transcription, Blocking Assay, RNA Sequencing, Plasmid Preparation, Software